Salamanca enhances oncology research with the vital business incubator project

The mayor of Salamanca, Carlos Garcia Carpio, confirmed that on Thursday April 10, a decisive step in its strategy to put the city as an international reference for entrepreneurship, science and research, with the first research of research.

During the presentation of this project, the Salamanca consultant highlighted municipal work with the diversification of the city’s productive model, focusing on knowledge, green economy, logistics and biological industry. “Today we start a new stage that will contribute to the city’s position as an international reference for entrepreneurship, science and research,” said Garcia Carpio.

In addition, as the mayor of the capital, the Standing Committee of Abioinnova has risen to the Executive Committee of the Municipal Association for Economic Promotion, Trade and Markets to propose to transfer advanced spaces and services to nine promising projects, including Ferofind treatments.

This project contains partners such as Miguel Angela (founder of Neurofix Pharma) and Monte Sinai Hospital in New York; With Adolfo García Sastre and Eugenio Santos, as members of the Scientific Committee and a distinguished group of investors, which will launch clinical trials for investigations developed by the impossible doctor in the American Center, by developing a technology based on viruses designed to treat different types of cancer: colon, breast, lymphoma, lympoma.

“In the pre -clinical stage, unusual results were achieved, 100 % healing of colon cancer and completely eliminating other tumors. “Clinical experiments will start in humans next year,” said the mayor of Salalamca.

This project, which will only be born in its initial phase of five direct jobs and ten indirect jobs, is part of the Salama Technology Initiative, which has a wide network of infrastructure to transfer research and development that is promoted with Junta de Castilla Y León and Salamanca University, among them Abioinnova.

In addition to Virofend Therapeutics, ABIONNNOVA will host eight other innovative projects in the next few days (Lubira Inganra, fungi consultant, Septivet (Loop Diagnostics), Lincbio-Tech (AptadeGradGra), Darnerinarystart Dynamics, 300K Solutions, Rartec and Tebrio Eugule). Sustainability, unification of Salamanca as a center for innovation.